Victory Capital Management
IMCR icon

Victory Capital Management’s Immunocore IMCR Stock Holding History

Victory Capital Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-169,851
Closed -$8.4M – 2557
2023
Q1 		$8.4M Buy
+169,851
New +$9.55M 0.01% 1081
2022
Q4 		– Sell
-8,186
Closed -$384K – 2652
2022
Q3 		$384K Hold
8,186
– – ﹤0.01% 2162
2022
Q2 		$305K Hold
8,186
– – ﹤0.01% 2231
2022
Q1 		$267K Hold
8,186
– – ﹤0.01% 2337
2021
Q4 		$280K Sell
8,186
-1,342
-14% -$48.6K ﹤0.01% 2401
2021
Q3 		$353K Hold
9,528
– – ﹤0.01% 2329
2021
Q2 		$372K Sell
9,528
-472
-5% -$18.2K ﹤0.01% 2341
2021
Q1 		$426K Buy
+10,000
New +$445K ﹤0.01% 2271

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management's IMCR Position: Q2 2023 in Review

Victory Capital Management sold out of Immunocore (IMCR) in Q2 2023, closing a stake of 169,851 shares — an estimated $8.4M sold.

Victory Capital Management first reported a position in IMCR in Q1 2021 and held it in 8 quarters. The position peaked at $8.4M in Q1 2023. 120 funds tracked by Wall St. Rank hold IMCR as of Q2 2023.

  • Victory Capital Management reported no remaining Immunocore position as of Q2 2023 after selling out during the quarter.
  • Victory Capital Management sold 169,851 Immunocore shares in Q2 2023, an estimated $8.4M.
  • Victory Capital Management first reported a position in Immunocore in Q1 2021 and held it in 8 quarters.
  • Victory Capital Management's Immunocore position peaked at $8.4M in Q1 2023.
  • 120 funds tracked by Wall St. Rank held Immunocore as of Q2 2023.

Based on Victory Capital Management's 13F filing for Q2 2023, filed 27 Jul 2023.